A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions

NCT04743362 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5010

Last updated 2026-04-23

No results posted yet for this study

Summary

The purpose of this study is to find out whether using noninvasive methods to study the appearance of lesions can improve diagnostic accuracy before a biopsy is required and help guide treatment planning. The database created to store these images is called an Image Repository, and it will be used to support clinical practice, teaching and training, and future research.The High-resolution OCT (Apollo Medical Optics) device ApolloVue® S100 Image System (medical device Class II) can provide both cross-sectional and en-face images with cellular information.

Conditions

  • Skin Lesion
  • Mucosal Lesion

Interventions

DIAGNOSTIC_TEST

Dermoscopic imaging

The skin lesion will be imaged before application of alcohol (spray/wipe) and after application of alcohol (spray/wipe). The dermatoscope/camera with dermoscopy imaging capabilities, including but not limited to VEOS® SLR (Canfield Scientific, Inc.), will be placed on/near the area(s) of interest. Images will be captured in polarized and/or nonpolarized modes and contact and/or non-contact modes.

DIAGNOSTIC_TEST

3-dimensional total body photography

Participants will stand in the center of an imaging station consisting of 92 high-resolution cameras. Image capture by all cameras will occur simultaneously, (approx. 3 milliseconds). Within a few minutes, specialized software will process and assemble the images into a 3D avatar - a digital model of the patient's skin - showing all his or her lesions.

DIAGNOSTIC_TEST

Confocal microscopy

CM imaging (Vivascope®, Caliber Imaging and Diagnostics, Rochester, NY) will be performed using an arm-mounted CM device (Vivascope1500, Caliber I.D., Inc.) or using a handheld CM device (Vivascope3000, Caliber I.D., Inc.).

DIAGNOSTIC_TEST

Optical Coherence Tomography imaging

OCT subsurface imaging shows structural-level morphology (epidermal and dermal layers) in skin down to the deeper reticular dermis.

DIAGNOSTIC_TEST

Ultrasound

US imaging allows assessment of depth, Doppler vascular imaging, and elastography features of skin lesions.

DIAGNOSTIC_TEST

Hyperspectral imaging

Hyperspectral imaging shows biochemical information regarding the distribution of skin melanin and hemoglobin50. SkinSpect™ is a form of a hyperspectral dermatoscope.

DIAGNOSTIC_TEST

Electrical impedance spectroscopy

Electrical impedance spectroscopy (EIS) measures skin's resistance to the flow of alternating electric currents to differentiate benign and malignant lesions.

DIAGNOSTIC_TEST

Patient self-imaging

Clinical and dermoscopy self-imaging by patients can be accomplished using mobile phone technology. In the case of dermoscopy, this requires a small dermatoscope attachment for the phone.

Sponsors & Collaborators

Principal Investigators

  • Manu Jain, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-02
Primary Completion
2031-08-02
Completion
2031-08-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04743362 on ClinicalTrials.gov